Stratified Blood Pressure Management After Endovascular Treatment for Acute Ischemic Stroke

Exclusion Criteria

• •Pre-stroke mRS score \> 1；
• •Comatose state (Glasgow Coma Scale \[GCS\] score \< 8);
• •Symptomatic intracerebral hemorrhage occurred before randomization;
• •Within the past 3 months, occurrence of acute ST-segment elevation myocardial infarction (MI), acute decompensated heart failure, QTc \> 500 ms, hospitalization or involuntary coronary intervention due to acute coronary syndrome, MI, or cardiac arrest; or heart failure (New York Heart Association \[NYHA\] class III/IV or left ventricular ejection fraction \< 35%); or known history of ventricular tachycardia;
• •History of severe renal insufficiency, acute renal failure, dialysis, or estimated glomerular filtration rate (eGFR) \< 20 ml/min/1.72m²;
• •History of severe hepatic disease, or Aspartate Aminotransferase (AST) and/or Alanine Aminotransferase (ALT) and/or Gamma-Glutamyl Transferase (GGT) ≥ 3×ULN and/or Total Bilirubin (TBIL) ≥ 2×ULN;
• •Aortic dissection, cervical artery dissection, or cerebral artery dissection; unruptured aortic aneurysm or cerebral aneurysm; or known arteriovenous malformation;
• •Comorbidities with a life expectancy \< 6 months (e.g., malignant tumors);
• •Pregnant or lactating women;
• •Participation in another clinical trial within the past 30 days;
• •Any clinical condition judged by the research team that might limit compliance with study procedures.